Cited by 347Neurotransmitter Receptor Influence on BehaviorTreatment of Major DepressionAnxiety, Depression, Psychometrics, Treatment, Cognitive Processes

The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.

Do animal models of anxiety predict anxiolytic-like effects of antidepressants?

Borsini, Franco, Podhorna, Jana, Marazziti, Donatella·2002·Psychopharmacology

DOI 10.1007/s00213-002-1155-6

Open this paper in CoChat — free account

Abstract

Chronically administered antidepressant drugs, particularly selective serotonin (5-HT) reuptake inhibitors (SSRIs), are clinically effective in the treatment of all anxiety disorders, while the clinical effectiveness of "traditional" anxiolytics, such as benzodiazepines (BDZs), is limited to generalised anxiety disorder or acute panic attacks. This implies that animal models of anxiety should be sensitive to SSRIs and other antidepressants in order to have predictive validity. We reviewed the literature on the effects of antidepressants in the so-called animal models of anxiety and found that only the isolation-induced calls in guinea-pig pups may reveal anxiolytic-like action of all antidepressant classes after acute administration. Some other models, such as marble-burying or conditioned-freezing behaviours, and isolation- or shock-induced ultrasonic vocalisation models, may detect anxiolytic-like activity of acutely administered antidepressants, although the sensitivity of these models is usually limited to SSRIs and other drugs affecting 5-HT uptake. The predictive validity of models of "anxiety", such as the plus-maze and light-dark transition tests or stress-induced hyperthermia, appears to be limited to BDZ-related drugs. Far less work has been done on chronic administration of antidepressants in animal anxiety models. Unless and until such studies have been undertaken, the true predictive value of the anxiety models will remain unknown.

Integrity signals

Registry

Crossref · 10.1007/s00213-002-1155-6

Cites

1 of 1 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Chronic antidepressant and clonidine treatment effects on conflict behavior in the rat
Commissaris, R. L., Ellis, D. M., Hill, T. J., Schefke, D. M., Becker, C. A., & Fontana, D. J. (1990) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(90)90058-p · Cited by 21

Show all 1 references

Sorted by citations

The microbiome-gut-brain axis during early life regulates the hippocampal serotonergic system in a sex-dependent manner
Clarke, G., Grenham, S., Scully, P., Fitzgerald, P., Moloney, R. D., Shanahan, F., Dinan, T. G., & Cryan, J. F. (2013) · Molecular Psychiatry · doi:10.1038/mp.2012.77 · Cited by 1,893
The ascent of mouse: advances in modelling human depression and anxiety
Cryan, J. F., & Holmes, A. (2005) · Nature Reviews Drug Discovery · doi:10.1038/nrd1825 · Cited by 1,198
Ethological and temporal analyses of anxiety-like behavior: The elevated plus-maze model 20 years on
Carobrez, A. P., & Bertoglio, L. J. (2005) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2005.04.017 · Cited by 993
The neurobiology and control of anxious states
Millan, M. J. (2003) · Progress in Neurobiology · doi:10.1016/s0301-0082(03)00087-x · Cited by 978
Resolving the neural circuits of anxiety
Calhoon, G. G., & Tye, K. M. (2015) · Nature Neuroscience · doi:10.1038/nn.4101 · Cited by 766
Marble burying reflects a repetitive and perseverative behavior more than novelty-induced anxiety
Thomas, A., Burant, A., Bui, N., Graham, D., Yuva-Paylor, L. A., & Paylor, R. (2009) · Psychopharmacology · doi:10.1007/s00213-009-1466-y · Cited by 698
Effects of Chronic Fluoxetine in Animal Models of Anxiety and Depression
Dulawa, S. C., Holick, K. A., Gundersen, B., & Hen, R. (2004) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300433 · Cited by 671
Role of GABA in anxiety and depression
Kalueff, A. V., & Nutt, D. (2006) · Depression and Anxiety · doi:10.1002/da.20262 · Cited by 563
Neuropeptide S
Xu, Y.-L., Reinscheid, R. K., Huitrón‐Reséndiz, S., Clark, S. D., Wang, Z., Lin, S. H., Brücher, F., Zeng, J., Ly, N. K., Henriksen, S. J., et al. (2004) · Neuron · doi:10.1016/j.neuron.2004.08.005 · Cited by 514
Digging and marble burying in mice: simple methods for in vivo identification of biological impacts
Deacon, R. M. J. (2006) · Nature Protocols · doi:10.1038/nprot.2006.20 · Cited by 508
Neuroligin-1 Deletion Results in Impaired Spatial Memory and Increased Repetitive Behavior
Blundell, J., Blaiss, C. A., Etherton, M. R., Espinosa, F., Tabuchi, K., Walz, C., Bolliger, M. F., Südhof, T. C., & Powell, C. M. (2010) · The Journal of Neuroscience · doi:10.1523/jneurosci.4517-09.2010 · Cited by 450
Recent advances in animal models of chronic antidepressant effects: The novelty-induced hypophagia test
Dulawa, S. C., & Hen, R. (2005) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2005.03.017 · Cited by 448
Bifidobacteria exert strain‐specific effects on stress‐related behavior and physiology in BALB /c mice
Savignac, H. M., Kiely, B., Dinan, T. G., & Cryan, J. F. (2014) · Neurogastroenterology & Motility · doi:10.1111/nmo.12427 · Cited by 418
Plasma and brain pharmacokinetic profile of cannabidiol (CBD), cannabidivarine (CBDV), Δ9-tetrahydrocannabivarin (THCV) and cannabigerol (CBG) in rats and mice following oral and intraperitoneal administration and CBD action on obsessive–compulsive behaviour
Deiana, S., Watanabe, A., Yamasaki, Y., Amada, N., Arthur, M., Fleming, S., Woodcock, H., Dorward, P. K., Pigliacampo, B., Close, S., et al. (2011) · Psychopharmacology · doi:10.1007/s00213-011-2415-0 · Cited by 422
Defensive burying in rodents: ethology, neurobiology and psychopharmacology
de Boer, S. F., & Koolhaas, J. M. (2003) · European Journal of Pharmacology · doi:10.1016/s0014-2999(03)01278-0 · Cited by 400
Genetic and Pharmacological Evidence of a Role for GABAB Receptors in the Modulation of Anxiety- and Antidepressant-Like Behavior
Mombereau, C., Kaupmann, K., Froestl, W., Sansig, G., van der Putten, H., & Cryan, J. F. (2004) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300413 · Cited by 353
Removing Obstacles in Neuroscience Drug Discovery: The Future Path for Animal Models
Markou, A., Chiamulera, C., Geyer, M. A., Tricklebank, M., & Steckler, T. (2009) · Neuropsychopharmacology · doi:10.1038/npp.2008.173 · Cited by 328
The age of anxiety: role of animal models of anxiolytic action in drug discovery
Cryan, J. F., & Sweeney, F. F. (2011) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2011.01362.x · Cited by 327
Evaluation of animal models of neurobehavioral disorders
van der Staay, F. J., Arndt, S. S., & Nordquist, R. E. (2009) · Behavioral and Brain Functions · doi:10.1186/1744-9081-5-11 · Cited by 319
The stress-induced hyperthermia paradigm as a physiological animal model for anxiety: A review of pharmacological and genetic studies in the mouse
Adriaan Bouwknecht, J., Olivier, B., & Paylor, R. E. (2007) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2006.02.002 · Cited by 256
What's wrong with my mouse model?
Kalueff, A. V., Wheaton, M., & Murphy, D. L. (2007) · Behavioural Brain Research · doi:10.1016/j.bbr.2007.01.023 · Cited by 285
A mouse model of posttraumatic stress disorder that distinguishes between conditioned and sensitised fear
Siegmund, A., & Wotjak, C. T. (2006) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2006.07.017 · Cited by 281
Anxiety-Related Behaviors in Mice
Crawley, J. N., & Bailey, K. (2008) · Frontiers in neuroscience · doi:10.1201/noe1420052343.ch5 · Cited by 277
MGS0039: a potent and selective group II metabotropic glutamate receptor antagonist with antidepressant-like activity
Chaki, S., Yoshikawa, R., Hirota, S., Shimazaki, T., Maeda, M., Kawashima, N., Yoshimizu, T., Yasuhara, A., Sakagami, K., Okuyama, S., et al. (2004) · Neuropharmacology · doi:10.1016/j.neuropharm.2003.10.009 · Cited by 254
Escitalopram versus citalopram: the surprising role of the R-enantiomer
S�nchez, C., B�ges�, K. P., Ebert, B., Reines, E. H., & Bræstrup, C. (2004) · Psychopharmacology · doi:10.1007/s00213-004-1865-z · Cited by 251
The role of serotonin receptor subtypes in treating depression: a review of animal studies
Carr, G. V., & Lucki, I. (2010) · Psychopharmacology · doi:10.1007/s00213-010-2097-z · Cited by 244
A combined marble burying–locomotor activity test in mice: A practical screening test with sensitivity to different classes of anxiolytics and antidepressants
Nicolas, L. B., Kolb, Y., & Prinssen, E. P. M. (2006) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2006.07.015 · Cited by 234
Effect of the selective 5-HT7 receptor antagonist SB 269970 in animal models of anxiety and depression
Wesołowska, A., Nikiforuk, A., Stachowicz, K., & Tatarczynska, E. (2006) · Neuropharmacology · doi:10.1016/j.neuropharm.2006.04.017 · Cited by 230
Serotonin 5-HT7 receptor agents: structure-activity relationships and potential therapeutic applications in central nervous system disorders
Leopoldo, M., Lacivita, E., Berardi, F., Perrone, R., & Hedlund, P. B. (2011) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2010.08.013 · Cited by 198
Genetics of Affective and Anxiety Disorders
Leonardo, E. D., & Hen, R. (2005) · Annual Review of Psychology · doi:10.1146/annurev.psych.57.102904.190118 · Cited by 191
Functional Aging in Male C57BL/6J Mice Across the Life-Span: A Systematic Behavioral Analysis of Motor, Emotional, and Memory Function to Define an Aging Phenotype
Yanai, S., & Endo, S. (2021) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2021.697621 · Cited by 171
Tryptophan depletion decreases the recognition of fear in female volunteers
Harmer, C. J., Rogers, R. D., Tunbridge, E. M., Cowen, P. J., & Goodwin, G. M. (2003) · Psychopharmacology · doi:10.1007/s00213-003-1401-6 · Cited by 165
Magnesium-deficient diet alters depression- and anxiety-related behavior in mice—influence of desipramine and Hypericum perforatum extract
Singewald, N., Sinner, C., Hetzenauer, A., Sartori, S. B., & Murck, H. (2004) · Neuropharmacology · doi:10.1016/j.neuropharm.2004.08.010 · Cited by 161
Antidepressant- and anxiolytic-like effects of selective neuronal NOS inhibitor 1-(2-trifluoromethylphenyl)-imidazole in mice
Volke, V., Wegener, G., Bourin, M., & Vasar, E. (2003) · Behavioural Brain Research · doi:10.1016/s0166-4328(02)00312-1 · Cited by 157
Experimental modeling of anxiety and depression
Kalueff, A. V., & Tuohimaa, P. (2004) · Acta Neurobiologiae Experimentalis · doi:10.55782/ane-2004-1526 · Cited by 162
Concomitant Deficits in Working Memory and Fear Extinction Are Functionally Dissociated from Reduced Anxiety in Metabotropic Glutamate Receptor 7-Deficient Mice
Callaerts‐Vegh, Z., Beckers, T., Ball, S. M., Baeyens, F., Callaerts, P., Cryan, J. F., Molnár, E., & D’Hooge, R. (2006) · Journal of Neuroscience · doi:10.1523/jneurosci.1497-06.2006 · Cited by 160
GENETIC APPROACHES TO THE STUDY OF ANXIETY
Gordon, J. A., & Hen, R. (2004) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.27.070203.144212 · Cited by 146
Oxidative and nitrosative stress pathways in the brain of socially isolated adult male rats demonstrating depressive- and anxiety-like symptoms
Filipović, D., Todorović, N., Bernardi, R. E., & Gass, P. (2017) · Brain Structure and Function · doi:10.1007/s00429-016-1218-9 · Cited by 138
Peripheral tumors induce depressive-like behaviors and cytokine production and alter hypothalamic-pituitary-adrenal axis regulation
Pyter, L. M., Pineros, V., Galang, J., McClintock, M. K., & Prendergast, B. J. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0811949106 · Cited by 142
Decreases in nestlet shredding of mice by serotonin uptake inhibitors: Comparison with marble burying
Li, X., Morrow, D., & Witkin, J. M. (2005) · Life Sciences · doi:10.1016/j.lfs.2005.08.002 · Cited by 137
Animal models of CNS disorders
McGonigle, P. (2013) · Biochemical Pharmacology · doi:10.1016/j.bcp.2013.06.016 · Cited by 142
Anxiolytic- and Antidepressant-Like Profile of ATC0065 and ATC0175: Nonpeptidic and Orally Active Melanin-Concentrating Hormone Receptor 1 Antagonists
Chaki, S., Funakoshi, T., Hirota-Okuno, S., Nishiguchi, M., Shimazaki, T., Iijima, M., Grottick, A. J., Kanuma, K., Omodera, K., Sekiguchi, Y., et al. (2005) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.104.081711 · Cited by 132
An Assessment of Anxiolytic Drug Screening Tests: Hormetic Dose Responses Predominate
Calabrese, E. J. (2008) · Critical Reviews in Toxicology · doi:10.1080/10408440802014238 · Cited by 132
Animal to human translational paradigms relevant for approach avoidance conflict decision making
Kirlić, N., Young, J. W., & Aupperle, R. L. (2017) · Behaviour Research and Therapy · doi:10.1016/j.brat.2017.04.010 · Cited by 140
Efficacy of the MCHR1 Antagonist N-[3-(1-{[4-(3,4-Difluorophenoxy)phenyl]methyl}(4-piperidyl))-4-methylphenyl]-2-methylpropanamide (SNAP 94847) in Mouse Models of Anxiety and Depression following Acute and Chronic Administration Is Independent of Hippocampal Neurogenesis
David, D. J. P., Klemenhagen, K. C., Holick, K. A., Saxe, M., Mendez‐David, I., Santarelli, L., Craig, D. A., Zhong, H., Swanson, C. J., Hegde, L. G., et al. (2007) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.106.109678 · Cited by 142
Different susceptibility of prefrontal cortex and hippocampus to oxidative stress following chronic social isolation stress
Martinović, J., Todorović, N., Bošković, M., Pajović, S. B., Demajo, M., & Filipović, D. (2014) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-014-2045-z · Cited by 131
Electric foot shock stress: a useful tool in neuropsychiatric studies
Bali, A., & Jaggi, A. S. (2015) · Reviews in the Neurosciences · doi:10.1515/revneuro-2015-0015 · Cited by 134
Deficient serotonin neurotransmission and depression-like serotonin biomarker alterations in tryptophan hydroxylase 2 (Tph2) loss-of-function mice
Jacobsen, J. P. R., Siesser, W. B., Sachs, B. D., Peterson, S. M., Cools, M. J., Setola, V., Folgering, J. H. A., Flik, G., & Caron, M. G. (2011) · Molecular Psychiatry · doi:10.1038/mp.2011.50 · Cited by 125
Effects of acute fluoxetine, paroxetine and desipramine on rats tested on the elevated plus-maze
Drapier, D., Bentué‐Ferrer, D., Laviolle, B., Millet, B., Allain, H., Bourin, M., & Reymann, J. (2006) · Behavioural Brain Research · doi:10.1016/j.bbr.2006.10.002 · Cited by 119
Anxiolytic and antidepressant effects of intracerebroventricularly administered somatostatin: Behavioral and neurophysiological evidence
Engin, E., Stellbrink, J., Treit, D., & Dickson, C. T. (2008) · Neuroscience · doi:10.1016/j.neuroscience.2008.09.037 · Cited by 119
Prevention of unpredictable chronic stress-related phenomena in zebrafish exposed to bromazepam, fluoxetine and nortriptyline
Marcon, M., Herrmann, A. P., Mocelin, R., Rambo, C. L., Koakoski, G., de Abreu, M. S., Conterato, G. M. M., Kist, L. W., Bogo, M. R., Zanatta, L. C. B., et al. (2016) · Psychopharmacology · doi:10.1007/s00213-016-4408-5 · Cited by 124
Animals, anxiety, and anxiety disorders: How to measure anxiety in rodents and why
Harro, J. (2017) · Behavioural Brain Research · doi:10.1016/j.bbr.2017.10.016 · Cited by 122
Potential anxiolytic and antidepressant effects of the selective 5-HT7 receptor antagonist SB 269970 after intrahippocampal administration to rats
Wesołowska, A., Nikiforuk, A., & Stachowicz, K. (2006) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2006.09.064 · Cited by 112
Reliability of common mouse behavioural tests of anxiety: A systematic review and meta-analysis on the effects of anxiolytics
Rosso, M., Wirz, R., Loretan, A. V., Sutter, N., da Cunha, C. T. P., Jarić, I., Würbel, H., & Voelkl, B. (2022) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2022.104928 · Cited by 128
Selective serotonin reuptake inhibitor reduces conditioned fear through its effect in the amygdala
Inoue, T., Li, X. B., Abekawa, T., Kitaichi, Y., Izumi, T., Nakagawa, S., & Koyama, T. (2004) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2004.06.061 · Cited by 108
Translational aspects of pharmacological research into anxiety disorders: The stress-induced hyperthermia (SIH) paradigm
Vinkers, C. H., van Bogaert, M. J. V., Klanker, M., Korte, S. M., Oosting, R. S., Hanania, T., Hopkins, S. C., Olivier, B., & Groenink, L. (2008) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2008.02.097 · Cited by 104
cAMP Response Element-Binding Protein Deficiency Allows for Increased Neurogenesis and a Rapid Onset of Antidepressant Response
Gur, T., Conti, A. C., Holden, J., Bechtholt, A. J., Hill, T. E., Lucki, I., Malberg, J. E., & Blendy, J. A. (2007) · Journal of Neuroscience · doi:10.1523/jneurosci.2051-07.2007 · Cited by 101
The Clinical Implications of Mouse Models of Enhanced Anxiety
Sartori, S. B., Landgraf, R., & Singewald, N. (2011) · Future Neurology · doi:10.2217/fnl.11.34 · Cited by 103
Attenuation of estrous cycle-dependent marble burying in female rats by acute treatment with progesterone and antidepressants
Schneider, T., & Popik, P. (2007) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2007.04.003 · Cited by 92
Pharmacological manipulations of judgement bias: A systematic review and meta-analysis
Neville, V., Nakagawa, S., Zidar, J., Paul, E. S., Lagisz, M., Melissa Bateson, B., Løvlie, H., & Mendl, M. (2019) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2019.11.008 · Cited by 95
Behavioral Disinhibition and Reduced Anxiety-like Behaviors in Monoamine Oxidase B-Deficient Mice
Bortolato, M., Godar, S. C., Davarian, S., Chen, K., & Shih, J. C. (2009) · Neuropsychopharmacology · doi:10.1038/npp.2009.118 · Cited by 90
Effects of buprenorphine on behavioral tests for antidepressant and anxiolytic drugs in mice
Falcón, E., Maier, K. L., Robinson, S. A., Hill‐Smith, T. E., & Lucki, I. (2014) · Psychopharmacology · doi:10.1007/s00213-014-3723-y · Cited by 87
The 5-HT7 receptor influences stereotypic behavior in a model of obsessive-compulsive disorder
Hedlund, P. B., & Sutcliffe, J. G. (2007) · Neuroscience Letters · doi:10.1016/j.neulet.2006.12.054 · Cited by 84
Paradoxical Anxiogenic Response of Juvenile Mice to Fluoxetine
Oh, J.-E., Zupan, B., Gross, S. S., & Tóth, M. (2009) · Neuropsychopharmacology · doi:10.1038/npp.2009.47 · Cited by 81
5-HT1A receptor agonist affects fear conditioning through stimulations of the postsynaptic 5-HT1A receptors in the hippocampus and amygdala
Li, X., Inoue, T., Abekawa, T., Weng, S.-M., Nakagawa, S., Izumi, T., & Koyama, T. (2006) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2005.12.008 · Cited by 84
Temporal structure of the rat's behavior in elevated plus maze test
Casarrubea, M., Roy, V., Sorbera, F., Magnússon, M. S., Santangelo, A., Arabo, A., & Crescimanno, G. (2012) · Behavioural Brain Research · doi:10.1016/j.bbr.2012.09.049 · Cited by 79
Transient inactivation of the infralimbic cortex induces antidepressant-like effects in the rat
Slattery, D. A., Neumann, I. D., & Cryan, J. F. (2011) · Journal of Psychopharmacology · doi:10.1177/0269881110368873 · Cited by 77
Anxiolytic and antidepressant-like activities of the novel and potent non-imidazole histamine H3 receptor antagonist ST-1283
Sadek, B. S., Bahí, A., Schwed, J. S., Walter, M., & Stark, H. (2014) · Drug Design Development and Therapy · doi:10.2147/dddt.s63088 · Cited by 76
Marble-burying behavior test as a murine model of compulsive-like behavior
Dixit, P. V., Sahu, R. A., & Mishra, D. K. (2020) · Journal of Pharmacological and Toxicological Methods · doi:10.1016/j.vascn.2020.106676 · Cited by 87
Preclinical Evaluation of Melanin-Concentrating Hormone Receptor 1 Antagonism for the Treatment of Obesity and Depression
Gehlert, D. R., Rasmussen, K., Shaw, J., Li, X., Ardayfio, P. A., Craft, L. S., Coşkun, T., Zhang, H. Y., Chen, Y., & Witkin, J. M. (2009) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.108.143362 · Cited by 77
Animal Models of Anxiety and Anxiolytic Drug Action
Treit, D., Engin, E., & McEown, K. (2009) · Current topics in behavioral neurosciences · doi:10.1007/7854_2009_17 · Cited by 79
Anxiolytic-Like Effects of Escitalopram, Citalopram, and R-Citalopram in Maternally Separated Mouse Pups
Fish, E. W., Faccidomo, S., Gupta, S., & Miczek, K. A. (2004) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.103.058206 · Cited by 76
Behavioral Phenotyping of Juvenile Long-Evans and Sprague-Dawley Rats: Implications for Preclinical Models of Autism Spectrum Disorders
Ku, K. M., Weir, R. K., Silverman, J. L., Berman, R. F., & Bauman, M. D. (2016) · PLOS ONE · doi:10.1371/journal.pone.0158150 · Cited by 74
Anxiolytic-like effects of acute and chronic treatment with Achillea millefolium L. extract
Baretta, I. P., Felizardo, R. A., Bimbato, V. F., dos Santos, M. G. J., Kassuya, C. A. L., Gasparotto, A., da Silva, C. R., Oliveira, S. M., Ferreira, J., & Andreatini, R. (2011) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2011.11.047 · Cited by 76
Experimental Models of Anxiety for Drug Discovery and Brain Research
Hart, P. C., Bergner, C., Smolinsky, A. N., Dufour, B. D., Egan, R. J., LaPorte, J. L., & Kalueff, A. V. (2009) · Methods in molecular biology · doi:10.1007/978-1-60761-058-8_18 · Cited by 74
Differential effects of acute and repeated citalopram in mouse models of anxiety and depression
Mombereau, C., Gur, T., Onksen, J. L., & Blendy, J. A. (2009) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145709990630 · Cited by 73
Increased novelty-induced motor activity and reduced depression-like behavior in neuropeptide Y (NPY)-Y4 receptor knockout mice
Tasan, R. O., Lin, S., Hetzenauer, A., Singewald, N., Herzog, H., & Sperk, G. (2009) · Neuroscience · doi:10.1016/j.neuroscience.2008.11.048 · Cited by 71
“…hyperthermia (Borsini et al., 1989; Lecci et al., 1990; Olivier et al., 2003; Van der Heyden et al., 1997) and the marble burying test (Borsini et al., 2002; Broekkamp et al., 1986; Nicolas et al., 2006; Njung’e and Handley, 1991; Xu et al., 2004), that are independent or even…”
BackgroundInfluential
Animal Models of Obsessive‐Compulsive Disorder
Witkin, J. M. (2008) · Current Protocols in Neuroscience · doi:10.1002/0471142301.ns0930s45 · Cited by 74
Predictive validity of a non-induced mouse model of compulsive-like behavior
Greene-Schloesser, D. M., van der Zee, E. A., Sheppard, D. K., Castillo, M. R., Gregg, K. A., Burrow, T., Foltz, H., Slater, M., & Bult‐Ito, A. (2011) · Behavioural Brain Research · doi:10.1016/j.bbr.2011.02.010 · Cited by 75
A mouse model of anxiety molecularly characterized by altered protein networks in the brain proteome
Szegő, É. M., Janáky, T., Szabó, Z., Csorba, A., Kompagne, H., Müller, G., Lévay, G. I., Simor, A., Juhász, G. D., & Kékesi, K. A. (2009) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2009.11.003 · Cited by 70
Chronic corticosterone administration induces negative valence and impairs positive valence behaviors in mice
Dieterich, A., Srivastava, P., Sharif, A., Stech, K., Floeder, J. R., Yohn, S. E., & Samuels, B. A. (2019) · Translational Psychiatry · doi:10.1038/s41398-019-0674-4 · Cited by 72
Anxiolytic-like and antidepressant-like effects produced by the selective 5-HT6 receptor antagonist SB-258585 after intrahippocampal administration to rats
Wesołowska, A., Nikiforuk, A., & Stachowicz, K. (2007) · Behavioural Pharmacology · doi:10.1097/fbp.0b013e3282d28f9c · Cited by 71
Differences in Anxiety-Like Behavior within a Batch of Wistar Rats Are Associated with Differences in Serotonergic Transmission, Enhanced by Acute SRI Administration, and Abolished By Serotonin Depletion
Näslund, J., Studer, E., Pettersson, R., Hagsäter, M., Nilsson, S., Nissbrandt, H., & Eriksson, E. (2015) · The International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyv018 · Cited by 70
Comparison of the kappa-opioid receptor antagonist DIPPA in tests of anxiety-like behavior between Wistar Kyoto and Sprague Dawley rats
Carr, G. V., & Lucki, I. (2010) · Psychopharmacology · doi:10.1007/s00213-010-1832-9 · Cited by 68
Agomelatine reverses the decrease in hippocampal cell survival induced by chronic mild stress
Dagytė, G., Crescente, I., Postema, F., Seguin, L., Gabriel, C., Mocaër, E., den Boer, J. A., & Koolhaas, J. M. (2010) · Behavioural Brain Research · doi:10.1016/j.bbr.2010.11.045 · Cited by 71
Repetitive behavior profile and supersensitivity to amphetamine in the C58/J mouse model of autism
Moy, S. S., Riddick, N. V., Nikolova, V. D., Teng, B. L., Agster, K. L., Nonneman, R. J., Young, N. B., Baker, L. K., Nadler, J. J., & Bodfish, J. W. (2013) · Behavioural Brain Research · doi:10.1016/j.bbr.2013.10.052 · Cited by 71
Neurochemical responses to antidepressants in the prefrontal cortex of mice and their efficacy in preclinical models of anxiety-like and depression-like behavior: a comparative and correlational study
Kobayashi, T., Hayashi, E., Shimamura, M., Kinoshita, M., & Murphy, N. P. (2008) · Psychopharmacology · doi:10.1007/s00213-008-1070-6 · Cited by 67
Anxiolytic effects of the melatonin MT2 receptor partial agonist UCM765: Comparison with melatonin and diazepam
Ochoa‐Sanchez, R., Rainer, Q., Comai, S., Spadoni, G., Bedini, A., Rivara, S., FRASCHINI, F., Mor, M., Tarzia, G., & Gobbi, G. (2012) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2012.07.003 · Cited by 67
Separation-induced ultrasonic vocalization in rat pups: Further pharmacological characterization
Iijima, M., & Chaki, S. (2005) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2005.11.005 · Cited by 66
P.2.d.023 Agomelatine reverses the decrease in hippocampal cell survival induced by chronic mild stress
Mocaër, E., Dagytė, G., Crescente, I., Postema, F., Seguin, L., Gabriel, C., den Boer, J. A., & Koolhaas, J. M. (2011) · European Neuropsychopharmacology · doi:10.1016/s0924-977x(11)70669-1 · Cited by 65
Duration of ultrasonic vocalizations in the isolated rat pup as a behavioral measure: Sensitivity to anxiolytic and antidepressant drugs
Hodgson, R. A., GUTHRIE, D., & Varty, G. B. (2007) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2007.09.005 · Cited by 63
Distinct Phenotypes of Shank2 Mouse Models Reflect Neuropsychiatric Spectrum Disorders of Human Patients With SHANK2 Variants
Eltokhi, A., Rappold, G., & Sprengel, R. (2018) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2018.00240 · Cited by 63
Zebrafish Models of Anxiety-Like Behaviors
Collier, A. D., Kalueff, A. V., & Echevarria, D. J. (2017) · Springer eBooks · doi:10.1007/978-3-319-33774-6_3 · Cited by 60
Synergistic effects of tandospirone and selective serotonin reuptake inhibitors on the contextual conditioned fear stress response in rats
Nishikawa, H., Inoue, T., Izumi, T., & Koyama, T. (2007) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2007.02.010 · Cited by 58
Altered anxiety-related behavior in nociceptin/orphanin FQ receptor gene knockout mice
Gavioli, E. C., Rizzi, A., Marzola, G., Zucchini, S., Regoli, D. C., & Calò, G. (2007) · Peptides · doi:10.1016/j.peptides.2007.04.012 · Cited by 58
Molecular Targets of Anxiety: From Membrane to Nucleus
Wu, L., Kim, S. S., & Zhuo, M. (2008) · Neurochemical Research · doi:10.1007/s11064-008-9679-8 · Cited by 57
The Elevated Plus-Maze Test: Differential Psychopharmacology of Anxiety-Related Behavior
Pawlak, C. R., Karrenbauer, B. D., Schneider, P., & Ho, Y. (2012) · Emotion Review · doi:10.1177/1754073911421374 · Cited by 57
Models of anxiety: Responses of mice to novelty and open spaces in a 3D maze
Ennaceur, A., Michalíková, S., VANRENSBURG, R., & Chazot, P. L. (2006) · Behavioural Brain Research · doi:10.1016/j.bbr.2006.07.001 · Cited by 54
Anosmia does not impair the anxiolytic-like effect of lavender essential oil inhalation in mice
Chioca, L. R., Antunes, V. D., Ferro, M. M., Losso, E. M., & Andreatini, R. (2013) · Life Sciences · doi:10.1016/j.lfs.2013.03.012 · Cited by 55
Serotonin transporter density and anxiolytic-like effects of antidepressants in mice
Mirza, N. R., Nielsen, E. Ø., & Troelsen, K. B. (2007) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2007.01.020 · Cited by 55

Authors: Borsini, F., Podhorna, J., & Marazziti, D.
Affiliations: Boehringer Ingelheim (Germany) (DE)
University of Pisa (IT)
ORCID: Marazziti, Donatella
Venue: Psychopharmacology
Publisher: Springer Science and Business Media LLC
Published: 2002-09-01
Volume: 163
Issue: 2
Pages: 121-141
ISSN: 0033-3158 (ISSN-L)
1432-2072
DOI: 10.1007/s00213-002-1155-6
OpenAlex: W2069192879
Cited by: 347
References: 1
Citations by year: 2026: 1 · 2025: 2 · 2024: 8 · 2023: 12 · 2022: 8 · 2021: 10 · 2020: 12 · 2019: 11 · 2018: 14 · 2017: 12 · 2016: 14 · 2015: 17 · 2014: 21 · 2013: 9 · 2012: 12
FWCI: 6.04
Type: journal article
Language: en
Open access: closed
Licence: www.springer.com/tdm (tdm)
Locations: Psychopharmacology (publishedVersion)
PubMed (publishedVersion)
Topics: Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
Social Sciences › Psychology › Experimental and Cognitive Psychology › Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes
Keywords: animal models of anxiety, antidepressants, anxiolytic-like effects, selective serotonin reuptake inhibitors, benzodiazepines, predictive validity, marble burying test, conditioned freezing, ultrasonic vocalizations, plus-maze test, light-dark transition test, stress-induced hyperthermia, anxiety disorders
MeSH terms: Animals, Antidepressive Agents, Tricyclic, Anxiety, Disease Models, Animal, Forecasting, Humans, Anti-Anxiety Agents

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Do animal models of anxiety predict anxiolytic-like effects of antidepressants?

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks